Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection
European Archives of Oto-Rhino-Laryngology · 08.11.2026
DOI: 10.1007/s00405-026-10799-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 08.11.2026. Verfasst von Luigi Falchetta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy. lfalchetta@unisa.it. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy. lfalchetta@unisa.it.
- Division of Ear, Nose, and Throat, University Hospital S. Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
- Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Zitieren
APA
Falchetta, L., Montanino, A., & Scarpa, A. (2026). Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10799-4
Vancouver
Falchetta L, Montanino A, Scarpa A. Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-026-10799-4
BibTeX
@article{Falchetta2026,
author = {Falchetta, Luigi and Montanino, Arianna and Scarpa, Alfonso},
title = {Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
doi = {10.1007/s00405-026-10799-4}
}
EUVIMED